Last reviewed · How we verify
NCT05682742
Clinical Investigation of the da Vinci Surgical System
NA trial testing Robotic-assisted Surgery in Thymoma in 53 participants. Participants enrolled and being followed up; not accepting new ones.
24 May 2023
Quick facts
| Lead sponsor | Intuitive Surgical |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 53 |
| Start date | 12 December 2022 |
| Primary completion | 24 May 2023 |
| Estimated completion | 31 August 2028 |
| Sites | 4 locations across United States |
Drugs / interventions tested
- Robotic-assisted Surgery
Conditions studied
- Thymoma — all drugs for Thymoma →
- Mediastinal Tumor — all drugs for Mediastinal Tumor →
- Gynecologic Disease — all drugs for Gynecologic Disease →
- Gynecologic Cancer — all drugs for Gynecologic Cancer →
Sponsor
Intuitive Surgical — full company profile →
Who can join
21 and older, any sex, with Thymoma or Mediastinal Tumor. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This prospective, multicenter, single-arm study is being conducted to confirm safety, effectiveness, and usability of da Vinci Surgical System in performing robotic-assisted surgical procedures.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A prospective, nonrandomized clinical investigation of the da Vinci surgical system model IS5000.
Merritt RE, Teixeira A, Needleman B, Meara M, et al · · 2025 · PMID 41032176 · DOI 10.1007/s11701-025-02837-w
Verify or expand the search:
- PubMed search for NCT05682742
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Thymoma
Currently open trials in the same condition.
- NCT06730308 — Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma · Phase 2 · recruiting
- NCT06692062 — Hypofractionated Radiotherapy for Thymic Epithelial Tumors · NA · recruiting
- NCT06029621 — Robot-assisted vs VATS for Thymoma · NA · recruiting
- NCT06301945 — Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors · recruiting
- NCT05214612 — Predictors and Prognostic Factors of Myasthenia Gravis Outcome · recruiting
Other Intuitive Surgical trials
Trials by the same sponsor.
- NCT07346066 — IS-001 Injection in Patients Undergoing Robotic-Assisted Colorectal Surgery · Phase 3 · not yet recruiting
- NCT07259759 — JURA Study - Observational First-in-human Feasibility Study · completed
- NCT06434727 — Evaluating Intuitive 3D Models in Preoperative Surgical Planning for Thoracic and Colorectal Procedures. · completed
- NCT06308120 — A Trial to Compare Robotic Assisted Bronchoscopy Ion's Clinical Utility for Peripheral Lung Nodule Access and Diagnosis · NA · active not recruiting
- NCT05954767 — IS-001 Injection in Patients Undergoing Robotic-Assisted Gynecological Surgery · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05682742 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Intuitive Surgical
- Last refreshed: 3 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05682742.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing